Evidence map›Paper›PMID 36769373›Full record

ArticleInternational journal of molecular sciences2023

LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis.

Hongxia Liu, Qianping Chen, Wang Zheng, Yuchuan Zhou, Yang Bai, Yan Pan, Jianghong Zhang, Chunlin Shao

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hongxia LiuInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.ORCID 0000-0002-3099-8911
Qianping ChenInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Wang ZhengInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Yuchuan ZhouInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Yang BaiInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Yan PanInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Jianghong ZhangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Chunlin ShaoInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.ORCID 0000-0001-9336-9912
Shanghai Medical College of Fudan University · CN

Funding

Foundation of Science and Technology Department of Henan Province, China 222102310495National Innovation and Entrepreneurship Training Program for college students 202210475086National Natural Science Foundation of China 32171235, 12235004, 12175044
6 · The paper itself

Abstract

Radioresistance remains a serious obstacle encountered in the radiotherapy of nasopharyngeal carcinoma (NPC). Both mRNAs and non-coding RNAs (ncRNAs), including long ncRNA (lncRNA) and microRNA (miRNA), play essential roles in radiosensitivity. However, the comprehensive expression profiles and competing endogenous RNA (ceRNA) regulatory networks among lncRNAs, miRNAs, and mRNAs in NPC radioresistance are still bewildering. In this study, we performed an RNA-sequencing (RNA-seq) assay in the radioresistant NPC cells CNE2R and its parental cells CNE2 to identify the differentially expressed lncRNAs, miRNAs, and mRNAs. The ceRNA networks containing lncRNAs, miRNAs, and mRNAs were predicted on the basis of the Pearson correlation coefficients and authoritative miRanda databases. In accordance with bioinformatic analysis of the data of the tandem mass tag (TMT) assay of CNE2R and CNE2 cells and the gene chip assay of radioresistant NPC samples in pre- and post-radiotherapy, the radioresistance-related signaling network of lncRNA CASC19, miR-340-3p, and FKBP5 was screened and further verified using an RT-qPCR assay. CASC19 was positively associated with FKBP5 expression while negatively correlated with miR-340-3p, and the target binding sites of CASC19/miR-340-3p and miR-340-3p/FKBP5 were confirmed using a dual-luciferase reporter assay. Moreover, using an mRFP-GFP-LC3 maker, it was found that autophagy contributed to the radioresistance of NPC. MiR-340-3p inhibition or FKBP5 overexpression could rescue the suppression of autophagy and radioresistance induced by CASC19 knockdown in CNE2R cells. In conclusion, the CASC19/miR-340-3p/FKBP5 network may be instrumental in regulating NPC radioresistance by enhancing autophagy, which provides potential new therapeutic targets for NPC.

Indexed as

CarcinomaMicroRNAsNasopharyngeal NeoplasmsRNA, Long NoncodingCell Line, TumorGene Expression Regulation, NeoplasticHumansNasopharyngeal CarcinomaRNA, MessengerTacrolimus Binding Protein 5MicroRNAsMIRN340 microRNA, humanRNA, Long NoncodingRNA, MessengerTacrolimus Binding Protein 5autophagyFKBP5lncRNA CASC19miR-340-3pnasopharyngeal carcinomaradioresistance

Identifiers

PMID36769373
PMCPMC9917593
OpenAlexW4319318823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.